October 9, 2020 11:46 AM EDTUpdated October 9, 10:48 PM

Parker Institute summoned the neoantigen pioneers to compare their prediction algorithms. And they have some suggestions for the field

What makes a good neoantigen?

For all the promises of the bold new approach to cancer vaccines and therapies — zeroing in on specific mutated antigens …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Park­er In­sti­tute sum­moned the neoanti­gen pi­o­neers to com­pare their pre­dic­tion al­go­rithms. And they have some sug­ges­tions for the field